173 related articles for article (PubMed ID: 23559676)
21. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
22. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
23. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
[TBL] [Abstract][Full Text] [Related]
24. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment.
Lye WC; Lee EJ
Ann Acad Med Singap; 1992 Nov; 21(6):760-4. PubMed ID: 1295414
[TBL] [Abstract][Full Text] [Related]
25. Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial.
Santos F; Moreno ML; Neto A; Ariceta G; Vara J; Alonso A; Bueno A; Afonso AC; Correia AJ; Muley R; Barrios V; Gómez C; Argente J
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1190-7. PubMed ID: 20522533
[TBL] [Abstract][Full Text] [Related]
26. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
[TBL] [Abstract][Full Text] [Related]
27. Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.
Laowalert S; Khotavivattana T; Wattanachanya L; Luangjarmekorn P; Udomkarnjananun S; Katavetin P; Eiam-Ong S; Praditpornsilpa K; Susantitaphong P
Nephrology (Carlton); 2020 Feb; 25(2):163-171. PubMed ID: 30980579
[TBL] [Abstract][Full Text] [Related]
28. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
[TBL] [Abstract][Full Text] [Related]
29. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.
De Paola L; Coppolino G; Bolignano D; Buemi M; Lombardi L
Ther Apher Dial; 2010 Dec; 14(6):566-71. PubMed ID: 21118364
[TBL] [Abstract][Full Text] [Related]
31. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
Yalçinkaya F; Ince E; Tümer N; Ensari A; Ozkaya N
Pediatr Int; 2000 Feb; 42(1):53-7. PubMed ID: 10703235
[TBL] [Abstract][Full Text] [Related]
32. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.
Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G
Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854
[TBL] [Abstract][Full Text] [Related]
33. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
Lanes R
Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal administration of recombinant human growth hormone in children with end-stage renal disease.
Gipson DS; Kausz AT; Striegel JE; Melvin TR; Astrom LJ; Watkins SL
Pediatr Nephrol; 2001 Jan; 16(1):29-34. PubMed ID: 11198599
[TBL] [Abstract][Full Text] [Related]
35. Responses of bone turnover markers and bone mineral density to growth hormone therapy in children with isolated growth hormone deficiency and multiple pituitary hormone deficiencies.
Kandemir N; Gonc EN; Yordam N
J Pediatr Endocrinol Metab; 2002 Jun; 15(6):809-16. PubMed ID: 12099391
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
37. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
Mathias R; Salusky I; Harman W; Paredes A; Emans J; Segre G; Goodman W
J Am Soc Nephrol; 1993 Jun; 3(12):1938-46. PubMed ID: 8338926
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India.
Sankarasubbaiyan S; Abraham G; Soundararajan P; Chandrasekaran V; Padma G
Hemodial Int; 2005 Jan; 9(1):63-7. PubMed ID: 16191055
[TBL] [Abstract][Full Text] [Related]
39. Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients.
Piscitelli J; Cabansag MR; Silverstein DM
J Pediatr Endocrinol Metab; 1999; 12(6):879-86. PubMed ID: 10614547
[TBL] [Abstract][Full Text] [Related]
40. Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.
Fehmi H; Osman Y; Bhat S; Nguyen K; Daramola O; Cantor T; Monier-Faugere MC; Yee J; Malluche HH
Clin Nephrol; 2009 Mar; 71(3):267-75. PubMed ID: 19281737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
